Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients

por de Jongh, F E, van Veen, R N, Veltman, S J, de Wit, R, van der Burg, M E L, van den Bent, M J, Planting, ASTh, Graveland, W J, Stoter, G, Verweij, J
Publicado 2003

Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients

por de Kruijff, I. E., Sieuwerts, A. M., Beije, N., Prager - van der Smissen, W. J. C., Angus, L., Beaufort, C. M., Van, M. N., Oomen - de Hoop, E., Jager, A., Hamberg, P., de Jongh, F. E., Kraan, J., Martens, J. W. M., Sleijfer, S.
Publicado 2021